Resistance to chemotherapy remains a major barrier to the successful treatment of cancer. To understand mechanisms underlying docetaxel resistance in breast cancer, we use an insertional mutagenesis strategy to identify proteins whose overexpression confers resistance, scientists writing in the journal
